Biotech Archives - Page 89 of 795

3 minute read

Nexalin Technology Announces Results Of Clinical Study Validating Its Gen-2 tACS Device For Reducing Pain Among Veterans With Mild Traumatic Brain Injury At University Of California, San Diego

March 28, 8:36 AM

Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control groupThe data supports the Company's strategy to offer military and civilian physicians a

NXL

1 minute read

Neurocrine Biosciences Announces Initiation Of Phase 1 Clinical Study Evaluating Effects Of NBI-1065890, A Second-Generation VMAT2 Inhibitor, In Healthy Adults

By Benzinga Newsdesk

March 28, 8:34 AM

Neurocrine Biosciences, Inc. (NASDAQ:NBIX), today announced the initiation of its Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound

NBIX

3 minute read

Biodexa’s MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers; Shares Spike Higher

By Benzinga Newsdesk

March 28, 8:19 AM

Topline Results For Progression-Free Survival Expected In Q2 2024CARDIFF, UK / ACCESSWIRE / March 28, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) ("Biodexa"), an acquisition-focused biopharmaceutical company, is

BDRX

4 minute read

4DMT Announces Update On Regulatory Interactions And Development Path For 4D-710 For Treatment Of Cystic Fibrosis

By Benzinga Newsdesk

March 28, 8:10 AM

Conducted initial pivotal study interactions with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA); Company has clear registration path for 4D-710 for treatment of cystic fibrosis (CF) lung

FDMT

1 minute read

EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications

By Vandana Singh

March 28, 6:45 AM

Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.

IPA

2 minute read

US Intelligence Claims Chinese Pharma Giant Illegally Shared Secrets With Beijing

By Benzinga Neuro

March 28, 3:13 AM

U.S. intelligence officials have informed senators that WuXi AppTec, a Chinese pharmaceutical company, allegedly transferred U.S. intellectual property to Beijing without authorization. This news comes amid concerns that certain Chinese biotech firms are providing technology or research and development for use by the Chinese military.

WXIBF

3 minute read

PharmAla’s Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development

By Lara Goldstein

March 27, 6:56 PM

The U.S. Patent and Trademark Office (USPTO) has granted PharmAla Biotech Holdings (OTC:MDXXF) a national patent covering the…

MDXXF

1 minute read

Sagimet Biosciences Announces Completion Of Phase 1 Hepatic Impairment Study With FASN Inhibitor Denifanstat

By Benzinga Newsdesk

March 27, 4:19 PM

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today

SGMT

2 minute read

Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook

By Surbhi Jain

March 27, 3:00 PM

Merck acquired sotatercept via its $11 billion acquisition of Acceleron Pharma, underscoring a commitment to advancing innovative therapies.

MRK

2 minute read

Medtronic’s Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA’s Muster, Shares Gain

By Vandana Singh

March 27, 2:14 PM

FDA approves Medtronic's Evolut FX+ TAVR system for severe aortic stenosis. Enhanced coronary access, maneuverability for diverse anatomies. Early Commercial Experience in spring 2024.

MDT